ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
907.8 EUR
+2.4 (+0.27%)
Overall 1LLY gets a fundamental rating of 6 out of 10. We evaluated 1LLY against 54 industry peers in the Pharmaceuticals industry. 1LLY has an excellent profitability rating, but there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth. These ratings could make 1LLY a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
1LLY had positive earnings in the past year.
In the past year 1LLY had a positive cash flow from operations.
Each year in the past 5 years 1LLY has been profitable.
In the past 5 years 1LLY always reported a positive cash flow from operatings.
1.2 Ratios
1LLY has a better Return On Assets (16.02%) than 92.59% of its industry peers.
1LLY has a Return On Equity of 77.38%. This is amongst the best in the industry. 1LLY outperforms 98.15% of its industry peers.
The Return On Invested Capital of 1LLY (28.84%) is better than 96.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1LLY is significantly above the industry average of 13.79%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
The Profit Margin of 1LLY (30.99%) is better than 98.15% of its industry peers.
1LLY's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 44.41%, 1LLY belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
Looking at the Gross Margin, with a value of 83.03%, 1LLY belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
Compared to 5 years ago, 1LLY has less shares outstanding
1LLY has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.43 indicates that 1LLY is not in any danger for bankruptcy at the moment.
1LLY has a better Altman-Z score (8.43) than 94.44% of its industry peers.
1LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as 1LLY would need 6.60 years to pay back of all of its debts.
1LLY has a Debt to FCF ratio (6.60) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.72 is on the high side and indicates that 1LLY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.72, 1LLY is doing worse than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.43 |
ROIC/WACC3.12
WACC9.25%
2.3 Liquidity
A Current Ratio of 1.55 indicates that 1LLY should not have too much problems paying its short term obligations.
The Current ratio of 1LLY (1.55) is better than 64.81% of its industry peers.
1LLY has a Quick Ratio of 1.24. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY has a Quick ratio of 1.24. This is in the better half of the industry: 1LLY outperforms 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.22%, which is quite impressive.
The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
1LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.41%.
1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.53% on average over the next years. This is a very strong growth
1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.88% yearly.
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 48.65, 1LLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 62.96% of the companies listed in the same industry.
1LLY is valuated expensively when we compare the Price/Earnings ratio to 26.57, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 32.89, which means the current valuation is very expensive for 1LLY.
Based on the Price/Forward Earnings ratio, 1LLY is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
1LLY is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.65 | ||
| Fwd PE | 32.89 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 157.17 | ||
| EV/EBITDA | 36.91 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of 1LLY may justify a higher PE ratio.
1LLY's earnings are expected to grow with 45.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)2.94
EPS Next 2Y58.19%
EPS Next 3Y45.43%
5. Dividend
5.1 Amount
1LLY has a yearly dividend return of 0.65%, which is pretty low.
1LLY's Dividend Yield is comparable with the industry average which is at 1.85.
With a Dividend Yield of 0.65, 1LLY pays less dividend than the S&P500 average, which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
5.2 History
The dividend of 1LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
28.28% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
1LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
BIT:1LLY (12/19/2025, 7:00:00 PM)
907.8
+2.4 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap858.22B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80.54
Price Target913.35 (0.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
Yearly Dividend4.21
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)15.92%
PT rev (3m)18.42%
EPS NQ rev (1m)1.69%
EPS NQ rev (3m)4.05%
EPS NY rev (1m)2.22%
EPS NY rev (3m)4.57%
Revenue NQ rev (1m)1.15%
Revenue NQ rev (3m)2.96%
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)3.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.65 | ||
| Fwd PE | 32.89 | ||
| P/S | 17.02 | ||
| P/FCF | 157.17 | ||
| P/OCF | 62.98 | ||
| P/B | 42.52 | ||
| P/tB | 88.36 | ||
| EV/EBITDA | 36.91 |
EPS(TTM)18.66
EY2.06%
EPS(NY)27.6
Fwd EY3.04%
FCF(TTM)5.78
FCFY0.64%
OCF(TTM)14.41
OCFY1.59%
SpS53.32
BVpS21.35
TBVpS10.27
PEG (NY)0.57
PEG (5Y)2.94
Graham Number94.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.43 |
F-Score7
WACC9.25%
ROIC/WACC3.12
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.24%
EBIT Next 3Y46.41%
EBIT Next 5Y32.15%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / 1LLY.MI FAQ
What is the fundamental rating for 1LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
Can you provide the valuation status for ELI LILLY & CO?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
Can you provide the profitability details for ELI LILLY & CO?
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for 1LLY stock?
The Price/Earnings (PE) ratio for ELI LILLY & CO (1LLY.MI) is 48.65 and the Price/Book (PB) ratio is 42.52.
How financially healthy is ELI LILLY & CO?
The financial health rating of ELI LILLY & CO (1LLY.MI) is 5 / 10.